148 related articles for article (PubMed ID: 38108073)
1. Reduced expression of secretogranin VGF in laryngeal squamous cell carcinoma.
Gabanella F; Maftei D; Colizza A; Rullo E; Riminucci M; Pasqualucci E; Di Certo MG; Lattanzi R; Possenti R; Corsi A; Greco A; De Vincentiis M; Severini C; Ralli M
Oncol Lett; 2024 Jan; 27(1):37. PubMed ID: 38108073
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
3. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
4. BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma.
Wang N; Huang X; Cheng J
PeerJ; 2022; 10():e12871. PubMed ID: 35178302
[TBL] [Abstract][Full Text] [Related]
5. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
Wang JL; Wang X; Yang D; Shi WJ
Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
[TBL] [Abstract][Full Text] [Related]
6. The Novel Circular RNA circTRIO Silence Inhibits the Progression of Laryngeal Squamous Cell Carcinoma.
Wang J; He S; Wang D; Jing Y; Shen W; Huang A; Zhou Z; Liu H
DNA Cell Biol; 2023 Jul; 42(7):421-432. PubMed ID: 37219914
[TBL] [Abstract][Full Text] [Related]
7. lncRNA NORAD, soluble ICAM1 and their correlations may be related to the regulation of the tumor immune microenvironment in laryngeal squamous cell carcinoma (LSCC).
Horozoglu C; Bal G; Kabadayı B; Hakan MT; Sönmez D; Nacarkahya G; Verim A; Yaylım İ
Pathol Res Pract; 2023 Jun; 246():154494. PubMed ID: 37172522
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
10. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
11. [Roles and mechanisms of m
Yan BR; Wang P; Li YS; Yang LK; Li QY; Kan X; Wang JT; Sun YN
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1470-1478. PubMed ID: 36707952
[No Abstract] [Full Text] [Related]
12. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
Liu C; Lu Z; Liu H; Zhuang S; Guo P
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
[TBL] [Abstract][Full Text] [Related]
13. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma.
Lan L; Cao H; Zhao L; Cui W; Wang B
Open Med (Wars); 2023; 18(1):20230727. PubMed ID: 37333450
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of zinc finger protein 71 in laryngeal squamous cell carcinoma tissues and its potential molecular mechanism and clinical significance: a study based on immunohistochemistry staining and data mining.
Jiang FC; Luo JY; Dang YW; Lu HP; Li DM; Huang ZG; Tang YL; Fang YY; Tang YX; Su YS; Dai WB; Pan SL; Feng ZB; Chen G; He J
World J Surg Oncol; 2022 Nov; 20(1):359. PubMed ID: 36369089
[TBL] [Abstract][Full Text] [Related]
15. Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.
Shuang Y; Yao X; Liu J; Niu J; Guo W; Li C
Hum Cell; 2022 Jul; 35(4):1084-1099. PubMed ID: 35545731
[TBL] [Abstract][Full Text] [Related]
16. Erchen decoction plus huiyanzhuyu decoction inhibits the cell cycle, migration and invasion and induces the apoptosis of laryngeal squamous cell carcinoma cells.
Zhou S; Luo Q; Tan X; Huang W; Feng X; Zhang T; Chen W; Yang C; Li Y
J Ethnopharmacol; 2020 Jun; 256():112638. PubMed ID: 32007633
[TBL] [Abstract][Full Text] [Related]
17. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
[TBL] [Abstract][Full Text] [Related]
18. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q
Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860
[TBL] [Abstract][Full Text] [Related]
19. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
[TBL] [Abstract][Full Text] [Related]
20. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]